ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
Erratum: Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.
Prithviraj Bose et al.PubMed ↗Publisher ↗
No numbers read from the abstract.